RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid Tumors
RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid Tumors
Not yet recruiting · NCT06545201 · Registry updated 2024-08-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid Tumors | KRAS G12V; T Cell Therapy | Not yet recruiting | Phase 1 | 2024-08-09 | NCT06545201 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Henan Cancer Hospital | 147 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henan Cancer Hospital | Zhengzhou | China | 67 |